Linton, United Kingdom

Kenneth Lyle Clark

USPTO Granted Patents = 16 

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 44(Granted Patents)


Location History:

  • Gilbertsville, PA (US) (2005)
  • Stevenage, GB (2006 - 2008)
  • Cambridge, GB (2008)
  • Hertfordshire, GB (2008)
  • Royston, GB (2008 - 2010)
  • Linton, GB (2007 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Kenneth Lyle Clark: A Pioneer in Innovative Therapeutics

Introduction

Kenneth Lyle Clark, an esteemed inventor based in Linton, GB, has made significant contributions to the field of biotechnology, boasting a portfolio of 16 patents. His work primarily focuses on novel compounds and their therapeutic applications, particularly involving human proteins critical for cell survival and regeneration.

Latest Patents

Among Kenneth's latest patents is a groundbreaking compound, detailed as a formula incorporating various chemically protected forms and structural components. The compound features an optionally substituted Caryl or Calkyl group, with intricate configurations that suggest potential therapeutic uses. Furthermore, he has developed patents related to Akt3 nucleic acids and polypeptides, which play a pivotal role in inhibiting cell death related to hypoxia, apoptosis, or necrosis. This work opens new avenues for gene therapy, highlighting his dedication to advancing medical science.

Career Highlights

Kenneth has collaborated with notable companies such as Asterand UK Limited and Aventis Pharmaceuticals Inc., where he leveraged his expertise to drive innovative solutions in the pharmaceutical industry. His career is characterized by a commitment to addressing critical health challenges through inventive approaches and scientific rigor, positioning him as a key figure in biotechnology advancements.

Collaborations

Throughout his career, Kenneth has worked alongside accomplished professionals, including Alexander W Oxford and Robert Alexander Coleman. These collaborations demonstrate the importance of teamwork in fostering innovative ideas and translating them into tangible inventions that can ultimately enhance patient care and therapeutic options.

Conclusion

Kenneth Lyle Clark stands out as a prominent inventor, whose patents and collaborations reflect a commitment to pushing the boundaries of innovation in biotechnology. His ongoing contributions have the potential to revolutionize therapeutic strategies, illustrating the profound impact of inventive minds in the pursuit of health advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…